Prescription Panic. / Mike Godwin.
by Godwin, Mike; SIRS Publishing, Inc.
Material type:
BookSeries: SIRS Enduring Issues 2003Article 64Business. Publisher: Reason, 2002ISSN: 1522-3191;.Subject(s): Bayer Corporation | Anthrax | Ciprofloxacin | Drugs -- Law and legislation | Intellectual property | Patents | Pharmaceutical industry | Prescription drugs | Public healthDDC classification: 050 Summary: "Before September 11 [2001], U.S. policy toward pharmaceutical patents was clear: The interests of the patent holder came first. However, the anthrax scare that surfaced in October has managed to shake that policy to its roots." (REASON) This article discusses how a public health scare can change policies related to pharmaceutical patents.
| Item type | Current location | Call number | Status | Date due |
|---|---|---|---|---|
Books
|
High School - old - to delete | REF SIRS 2003 Bus64 (Browse shelf) | Available |
Browsing High School - old - to delete Shelves Close shelf browser
| No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | ||
| REF SIRS 2003 Bus61 Consuming Rituals of the Suburban Tribe. / | REF SIRS 2003 Bus62 Color by Numbers. / | REF SIRS 2003 Bus63 How You Can Protect Your Privacy. / | REF SIRS 2003 Bus64 Prescription Panic. / | REF SIRS 2003 Bus65 The Enforcers. / | REF SIRS 2003 Bus66 Vehicle Safety Standards Outdated. / | REF SIRS 2003 Bus66 NHTSA Forfeits Oversight Role. / |
Articles Contained in SIRS Enduring Issues 2003.
Originally Published: Prescription Panic, Feb. 2002; pp. 32-37.
"Before September 11 [2001], U.S. policy toward pharmaceutical patents was clear: The interests of the patent holder came first. However, the anthrax scare that surfaced in October has managed to shake that policy to its roots." (REASON) This article discusses how a public health scare can change policies related to pharmaceutical patents.
Records created from non-MARC resource.
There are no comments for this item.